Literature DB >> 20659495

Pseudomonas exotoxin kills Drosophila S2 cells via apoptosis.

Ashima K Sharma1, David FitzGerald.   

Abstract

Pseudomonas exotoxin A (PE) is cytotoxic for eukaryotic cells because it enters cells by receptor-mediated endocytosis, translocates to the cell cytosol and ADP-ribosylates elongation factor 2 (EF2). However, the interaction of this toxin with eukaryotic cells and the mechanism of PE-mediated cell death have not been extensively characterized. The feasibility of carrying out a genome-wide RNAi screen, makes Drosophila melanogaster S2 cells as a good model system to identify essential genes in PE-mediated cytotoxicity, provided a suitable multi-well assay is developed. Here, using the alamarBlue viability assay, we show that Drosophila S2 cells are sensitive to PE at picomolar concentrations and that toxin treatments provoke an increase in caspase activity. This prompted us to use RNAi to characterize the mechanism of cell death. Results indicated that PE-mediated death of S2 cells was dependent on the presence of diphthamide, the post translational modification of EF2, and on the presence of Drice, the terminal caspase of insect cells. RNAi to drice or chemical inhibition of caspase action by z-VAD-fmk protected cells from PE-mediated death. Protection from death by RNAi or z-VAD-fmk did not interfere with toxin delivery to the cytosol leading to inhibition of protein synthesis. Using a convenient alamarBlue assay, our data confirms the cytotoxicity of PE for S2 cells and establishes apoptosis as the mode of PE-mediated death. This confirms the suitability of Drosophila cells as a convenient and simple model to elucidate the role of specific genes and proteins required for PE action. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20659495      PMCID: PMC3431163          DOI: 10.1016/j.toxicon.2010.07.007

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.035


  19 in total

Review 1.  Genetic control of programmed cell death in Drosophila melanogaster.

Authors:  Peter Cashio; Tom V Lee; Andreas Bergmann
Journal:  Semin Cell Dev Biol       Date:  2005-04       Impact factor: 7.727

Review 2.  Immunotoxin therapy of cancer.

Authors:  Ira Pastan; Raffit Hassan; David J Fitzgerald; Robert J Kreitman
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

3.  Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia.

Authors:  R J Kreitman; W H Wilson; K Bergeron; M Raggio; M Stetler-Stevenson; D J FitzGerald; I Pastan
Journal:  N Engl J Med       Date:  2001-07-26       Impact factor: 91.245

Review 4.  Elucidating the molecular mechanisms of bacterial virulence using non-mammalian hosts.

Authors:  S Mahajan-Miklos; L G Rahme; F M Ausubel
Journal:  Mol Microbiol       Date:  2000-09       Impact factor: 3.501

5.  Apoptosis induced by immunotoxins used in the treatment of hematologic malignancies.

Authors:  A Keppler-Hafkemeyer; R J Kreitman; I Pastan
Journal:  Int J Cancer       Date:  2000-07-01       Impact factor: 7.396

6.  Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin.

Authors:  Tilman Schneider-Poetsch; Jianhua Ju; Daniel E Eyler; Yongjun Dang; Shridhar Bhat; William C Merrick; Rachel Green; Ben Shen; Jun O Liu
Journal:  Nat Chem Biol       Date:  2010-01-31       Impact factor: 15.040

7.  Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers.

Authors:  Raffit Hassan; Susie Bullock; Ahalya Premkumar; Robert J Kreitman; Hedy Kindler; Mark C Willingham; Ira Pastan
Journal:  Clin Cancer Res       Date:  2007-09-01       Impact factor: 12.531

8.  Responses in refractory hairy cell leukemia to a recombinant immunotoxin.

Authors:  R J Kreitman; W H Wilson; D Robbins; I Margulies; M Stetler-Stevenson; T A Waldmann; I Pastan
Journal:  Blood       Date:  1999-11-15       Impact factor: 25.476

9.  Apoptosis induced by Pseudomonas exotoxin: a sensitive and rapid marker for gene delivery in vivo.

Authors:  P Hafkemeyer; U Brinkmann; M M Gottesman; I Pastan
Journal:  Hum Gene Ther       Date:  1999-04-10       Impact factor: 4.793

10.  The contribution of exoproducts to virulence of Pseudomonas aeruginosa.

Authors:  T I Nicas; B H Iglewski
Journal:  Can J Microbiol       Date:  1985-04       Impact factor: 3.226

View more
  6 in total

Review 1.  A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer.

Authors:  John E Weldon; Ira Pastan
Journal:  FEBS J       Date:  2011-06-02       Impact factor: 5.622

2.  Metabolomic markers reveal novel pathways of ageing and early development in human populations.

Authors:  Cristina Menni; Gabriella Kastenmüller; Ann Kristin Petersen; Jordana T Bell; Maria Psatha; Pei-Chien Tsai; Christian Gieger; Holger Schulz; Idil Erte; Sally John; M Julia Brosnan; Scott G Wilson; Loukia Tsaprouni; Ee Mun Lim; Bronwyn Stuckey; Panos Deloukas; Robert Mohney; Karsten Suhre; Tim D Spector; Ana M Valdes
Journal:  Int J Epidemiol       Date:  2013-07-08       Impact factor: 7.196

Review 3.  Development of Anti-Virulence Therapeutics against Mono-ADP-Ribosyltransferase Toxins.

Authors:  Miguel R Lugo; Allan R Merrill
Journal:  Toxins (Basel)       Date:  2020-12-25       Impact factor: 4.546

Review 4.  Advances on Delivery of Cytotoxic Enzymes as Anticancer Agents.

Authors:  Akmal M Asrorov; Bahtiyor Muhitdinov; Bin Tu; Sharafitdin Mirzaakhmedov; Huiyuan Wang; Yongzhuo Huang
Journal:  Molecules       Date:  2022-06-14       Impact factor: 4.927

5.  Structural complementation of the catalytic domain of pseudomonas exotoxin A.

Authors:  Erin L Boland; Crystal M Van Dyken; Rachel M Duckett; Andrew J McCluskey; Gregory M K Poon
Journal:  J Mol Biol       Date:  2013-11-08       Impact factor: 6.151

6.  HER2-specific recombinant immunotoxin 4D5scFv-PE40 passes through retrograde trafficking route and forces cells to enter apoptosis.

Authors:  Evgeniya Sokolova; Evgeniy Guryev; Andrey Yudintsev; Vladimir Vodeneev; Sergey Deyev; Irina Balalaeva
Journal:  Oncotarget       Date:  2017-03-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.